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Abstract—The use of a combination of IrCl3 with a series of ligands derived from the C2-symmetric diamine diphenylethanediamine 
(DPEN) forms a catalyst capable of the asymmetric hydrogenation of ketones in up to 85% ee.  © 2009 Elsevier Science. All rights 
reserved 
——— 
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Introduction 
Relatively few organometallic complexes derived from 
amine ligands have been reported to be effective at the 
control of asymmetric hydrogenation reactions,1-10 
particularly in comparison to the large numbers of 
diphosphine11,12 and mixed amine/phosphine13,14 ligands 
which have been reported. 
 In principle, amine-based ligands possess a potential 
advantage over phosphorus because they are relatively 
simple to prepare and less prone to decomposition reactions 
and oxidation. Of the diamine-containing systems which 
have been reported, a number have been applied to the 
catalysis of the reduction of ketones in high ee. In most 
cases, the complexes are of ruthenium, rhodium or iridium 
metals, whilst the ligands are frequently derived from the 
C2-symmetric 1,2-diphenylethylene-1,2-diamine 1 (R,R- or 
S,S-DPEN) or 1,2-diaminocyclohexane 2 (R,R- or S,S-
DACH). 
 An iridium-diamine complex has been prepared in situ 
through the combination of N,N’-dimethyl-DPEN 
(DiMeDPEN) with [Ir(COD)2]BF4. This gave products in 
up to 80% ee in hydrogenations of α-keto esters and 68% 
ee for acetophenone.1b.c Water soluble DiMeDPEN 
complexes of Ir(I) salts gave better results than Ru or Rh 
and 84% ee for the reduction of PhCOtBu.2 Complexes of 
R,R-DACH 2 and DiMeDPEN with [Ir(COD)2]BF4 have 
been used in the hydrogenation of α-keto esters.1a (up to 
72% and 31% ee respectively). The combination of (R,R)-
N-tosyl-DPEN 3 (R,R-TsDPEN) and [Ir(cod)Cl]2 in 
MeOH/toluene has been reported to be effective in the 


































  A number of amine-containing isolated complexes for 
ketone hydrogenation have been reported.5-10 The 
pentamethylcyclopentadienyl rhodium (III) and iridium 
(III) catalysts 4a and 4b respectively, derived from 
TsDPEN 3 have given excellent results.5 A closely related 
Ru(II)/arene complex 5 has also been reported to be highly 
effective.6 Ruthenium complexes 6 and 7 have also proved 
to be very enantioselective catalysts in ketone 
hydrogenation.7,8  
 In recently reported preliminary studies, we reported 
that N’-alkylated derivatives of TsDPEN 3 can be 
combined with IrCl3 to form a competent catalyst for the 
reduction of acetophenone derivatives in ees of up to 84% 
(Scheme 1).15 Although the activity of these catalysts is 
lower than that of phosphine-derived catalysts, their ease of 
preparation from stable materials and a simple Ir(III) 
complex makes them attractive as a simple system for the 
reduction of selected ketones. The use of iridium was also 
shown to be important; ruthenium or rhodium complexes 
formed catalysts which also reduced the arene ring of the 
substrate. In this paper, we report the synthesis and 
screening of a diverse series of TsDPEN derived ligands in 
















up to 84% ee  
Scheme 1: Asymmetric ketone reduction using a combination of IrCl3 and 
a diamine ligand.15 
Results and Discussion 
 In previous studies,15 we had examined only the 
tosylated derivatives of DPEN 1. In order to understand the 
importance of the structure of the sulfonamide part, a series 
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 Scheme 2: Preparation of ligands 9a- 9q. 
The ligands were prepared (Scheme 2) by the reaction of 
(S,S)-DPEN 1 with the appropriate sulfonylhalide in DCM 
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at 0oC, using triethylamine as a base, to give sulfonamides 
8a-8q. Reductive amination of each with propanal resulted 
in formation of ligands 9a-9q in good isolated yields. The 
incorporation of a N’-propyl group was selected as this had 
given the highest selectivity when used in the tosylated 
catalyst series.15 In each case the (S,S) enantiomers of 
diamines were prepared. 
 Each of the ligands was employed in the asymmetric 
hydrogenation of 2-methylacetophenone, using the 
conditions previously reported for the reduction.15 The 
results are summarized in Table 1. 2-Methylacetophenone 
was selected for study because it had given particularly 
promising results in preliminary results, and because ortho-
substituted substrates can be challenging substrates to 
reduce in high ee.16  
Table 1: Asymmetric hydrogenation of 2-methylacetophenone using IrCl3 













Entry Ligand Conv./% Ee/%  (R/S) 
1 9a 100 79 (R) 90:10 
2 9b 100 55 (R)  
3 9c 100 79 (R) 90:10 
4 9d 100 81 (R) 90:10 
5 9e 99 62 (R)  
6 9f 100 82 (R) 
7 9g 100 40 (R) 
8 9h 100 55 (R) 
9 9i 100 73 (R) 
10 9j  100 77 (R) 
11 9k 93 65 (R) 
12 9l 100 81 (R) 
13 9m 100 80 (R) 
14 9n 100 76 (R) 
15 9o 100 83 (R) 
16 9p 29 4 (R) 
17 9q 81 61 (R) 
a. Conditions: 1M 2-methylacetophenone in methanol (1 mL); 1% 
catalyst, 50 bar hydrogen, NaOH:catalyst = 30:1, 40 °C, 24 h.  
 
 Of the ligands tested, the best results were obtained 
using those with relatively unhindered aromatic rings 
containing electron withdrawing groups (entries 3, 4, 6, 12, 
13, 15). With the exception of ligand 9l, diamines 
containing substituents at the ortho-position(s) gave lower 
asymmetric inductions (entries 7-9), and those with two 
ortho-substituents were particularly poor, possibly for steric 
reasons. Electron-withdrawing groups on the aromatic ring 
provided a reduction in the activity and the 
enantioselectivity, whilst both non-aromatic rings gave 
incomplete conversions and correspondingly reduced ees. 
Of the ligands examined, the best was the 2-naphthalene 
sulfonyl derivative 9o, therefore this was selected for 


































 The enantioselectivities of the reductions using ligand 
9o are reasonably similar to those obtained with the N-tosyl 
derivative, although in some cases a marginally improved 
result was obtained (e.g. entries 2, 3, 5, 6, 8, 10, 14). In the 
case of tetralone 10g and 2,5-dimethoxyacetophenone 10d, 
ligand 9o was somewhat inferior.    
Table 2: Asymmetric hydrogenation of ketones using IrCl3 with diamine 












Entry Ligand Ketone Conv./% Ee/%  (R/S) 
1 9o 10a 100 71 (R) 
2 9o 10b 100 70 (R)  
3 9o 10c 99 54 (R) 
4 9o 10d 100 67 (R) 
5 9o 10e 100 85 (R)  
6 9o 10f 100 75 (R) 
7 9o 10g 100 52 (R) 
8 9o 10h 100 72 (R) 
9 9o 10i 100 67 (R) 
10 9o 10j  100 61 (R) 
11 9o 10k 100 65 (R) 
12 9o 10l 100 61 (R) 
13 9o 10m 100 62 (R) 
14 9o 10n 100 71 (R) 
15 9o 10o 100 72 (R) 
16 9d 10e 100 84 (R) 
17 9d 10d 100 71 (R) 
18 9d 10g 90 45 (R) 
19 9f 10e 98 80 (R) 
20 9f 10d 100 60 (R) 
21 9f 10g 99 53 (R) 
a. Conditions: 1M ketone in methanol (1 mL); 1% catalyst, 50 bar 
hydrogen, NaOH:catalyst = 30:1, 40 °C, 24 h.  
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Some of the best results were obtained with relatively 
hindered ortho-substituted ketones (e.g. 10a, 10b, 10e and 
10f). To complete this series of tests, ligands 9d and 9f 
were also tested against the more challenging ketones (also 
shown in Table 2). Competitive, but not sharply improved, 
results were obtained with these ligands. 
Conclusions 
In conclusion, a series of N’-alkyl–N-sulphonylated 
derivatives of the readily available and inexpensive 
diamine DPEN have been prepared and tested in 
asymmetric ketone hydrogenation reactions. In some cases, 
notably those of relatively sterically congested ketones 
(ortho-substituted arenas, tBu-substituted), the ees are high. 
Whilst not competitive with the best hydrogenation systems 
in terms of activity and ee, the simplicity of this 
hydrogenation system (i.e. it is compatible with the simple 
salt IrCl3) may in some cases provide an attractive 
alternative. The novel ligands and intermediates to them 
may find application in other asymmetric catalytic 
processes, including asymmetric transfer hydrogenation 
reactions.17 
Experimental section 
General experimental details, and the procedure for the 
hydrogenation reaction, have been described in a previous 
publication.15  
General procedure for synthesis of sulfonated DPEN 
derivatives: Compounds 8a – 8q were obtained by reaction 
between (S,S)-DPEN 1 and the correspondent 
sulfonylchloride (1:1) in DCM and Et3N overnight. With 
the exception of 8p all reactions were performed at 0oC. 
Although some of the monotosylated ligands have been 
described in the literature, only a few references contain 
experimental data, hence most were fully characterized. 
Below is a representative example; the other ligands are 
described in the Supporting Information. 
Naphthalene-2-sulfonic acid (2-amino-1,2-diphenyl-
ethyl)-amide 8o: (S,S)-DPEN 1 (0.3g, 1.4 mmol) was 
dissolved in DCM (20 cm3) and cooled to 0oC, then Et3N 
(0.21 cm3, 1.5 mmol) was added followed by  a solution of 
2-Naphthalenesulfonyl chloride (0.31 g, 1.4 mmol) in  
DCM (5 cm3) . The system was allowed to stay at rt and it 
was stirred overnight. The mixture was washed with water 
(10 cm3) and then the organic phase was separated, dried 
over dried MgSO4 and evaporated under reduced pressure 
to afford the crude product which was purified by silica gel 
chromatography (0 → 5 % v/v Methanol/DCM) to afford 
8o as a white solid (0.47 g, 1.1 mmol, 84%). mp 199 – 
201oC; [α]D27 = − 34 (c 0.55, CH3OH); νmax(neat)/cm−1: 
3386, 3330, 3059, 3029, 1589, 1495, 1455, 1417, 1311, 
1151, 1129, 875, 853, 750, 696, 662. δH (300 MHz; 
CDCl3)/ppm: 8.00 – 6.90 (17H, m, Ar-H), 6.20 (1H, br s, 
NH), 4.46 (1H, d, J 5.0, PhCHNHSO2R), 4.13 (1H, d, J 
5.0, PhCHNH2), 1.44 (2H, br s, NH2). δC (75 MHz; 
CDCl3)/ppm: 141.1, 139.1, 136.8, 134.4, 131.8, 129.1, 
128.8, 128.3, 128.2, 128.1, 128.0, 127.6, 127.4, 126.8, 
126.2 (Ar-C), 63.2 (CH), 60.3 (CH). HRMS calcd for 
C24H23N2O2S [M + H]+ 403.1472, found 403.1488.  
General procedure for N’-propyl-N-sulphonylDPEN 
derivatives: The N-propyl derivatives 9a – 9q were 
obtained by reductive amination of the mono sulfonylated 
derivative 8a – 8q with propanal. Below is a representative 
example; the other ligands are described in the Supporting 
Information. 
Naphthalene-2-sulfonic acid (1,2-diphenyl-2-
propylamino-ethyl)-amide 9o: To a stirred solution of 8o 
(0.20 g, 0.5 mmol) and molecular sieves (0.7 g) in dried 
methanol (10 cm3), was added propanal (0.035 cm3, 0.50 
mmol) followed by 2 drops of glacial acetic acid. The 
reaction was followed by TLC until the imine was formed 
(3 hours) and then sodium cyanoborohydride (0.13 g, 2.0 
mmol) was added and the reaction left to stir overnight at 
rt. The molecular sieves were filtered through filter paper 
and the solution was concentrated under reduced pressure. 
The residue was dissolved in chloroform (30 mL), washed 
with saturated NaHCO3 solution (20 mL) and then dried 
over anhydrous MgSO4. The solvent was removed to give a 
crude product which was purified by silica gel column 
chromatography (0 → 30 % v/v ethyl acetate/hexane) to 
afford 9o as a white solid (0.12 g, 0.27 mmol, 57 % ). mp 
148 – 151oC. [α]D27 = − 4 (c 0.37, CH3OH); 
νmax(neat)/cm−1: 3291, 3058, 2953, 2928, 2807, 2325, 1593, 
1494, 1453, 1330, 1158, 1149, 1072, 1053, 1021, 8914, 
839, 744, 697, 665. δH (300 MHz; CDCl3)/ppm: 8.00 – 6.85 
(17H, m, Ar-H), 4.32 (1H, d, J 8.0, PhCHNHSO2R), 3.61 
(1H, d, J 8.0, PhCHNHpropyl), 2.30 (2H, m, CH2), 1.35 
(3H, m, CH2 and NH), 0.81 (3H, t, J 7.3, CH3). δC (75 
MHz; CDCl3)/ppm: 139.2, 137.9, 136.8, 134.4, 131.8, 
129.1, 128.7, 128.5, 128.3, 128.1, 127.7, 127.6, 127.5, 
127.4, 127.3, 127.2, 126.9, 122.3 (Ar-C), 67.6 (CH), 63.1 
(CH), 48.9 (CH2), 23.1 (CH2), 11.5 (CH3). HRMS calcd for 
C27H29N2O2S [M + H]+ 445.1940, found 445.1944. 
Analysis of reduction products: 
1-(2-methylphenyl)ethanol: Enantiomeric excess and 
conversion determined by GC analysis (Chrompac 
cyclodextrin-β-236M-19 50m, gas He, T = 150 0C, P = 15 
psi, ketone 10.8 min, R isomer 15.6 min., S isomer 16.3 
min.); [α]D
32 = + 68.5 (c 0.54 in CHCl3) 83% ee (R) (lit.18 
[α]D
29 –72.1 (c 0.53, CHCl3) for 91% ee (S)). δH (300 MHz; 
CDCl3)/ppm: 7.49 – 7.06 (4H, m, Ar-H), 5.05 (1H, q, J 6.4, 
PHCHOH), 2.30 (3H, s, ArCH3), 1.41 (3H, d, J 6.4, CH3). 
δC (75 MHz; CDCl3)/ppm: 143.9, 134.2, 130.3, 127.1, 
126.3, 124.5 (Ar-C), 66.7, (CH), 23.9 (CH3), 18.9 (CH3). 
1-(2’-Methoxyphenyl)ethanol: Enantiomeric excess and 
conversion determined by GC analysis (Chrompac 
cyclodextrin-β-236M-19 50m, gas He, T = 140 0C, P = 15 
psi, ketone 31.3 min, S isomer 37.5 min., R isomer 39.0 
min.); [α]D33 = + 37 (c 0.67 in toluene) 71% ee (R) (lit.19 
[α]D
23 -63.0 (c 1.10 in toluene) > 99% ee (S)); δH (400 
MHz; CDCl3)/ppm: 7.34 (1H, dd, J 7.4 and 1.6, Ar-H), 
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7.25 (1H, td, J 7.8 and 1.8, Ar-H), 6.96 (1H, t, J 7.4, Ar-H), 
6.88 (1H, d, J 8.3, Ar-H), 5.09 (1H, q, J 6.5, PhCHCH3), 
3.86 (3H, s, OCH3), 2.72 (1H, br s, OH), 1.50 (3H, d, J 6.5, 
CH3); δC (100.6 MHz; CDCl3)/ppm: 156.6 (next to OCH3) 
133.4, 128.3, 126.1, 120.8, 110.4 (Ar-C), 66.6 (CH), 55.3 
(OCH3), 22.9 (CH3). 
1-(2’-Chlorophenyl)ethanol: Enantiomeric excess and 
conversion determined by GC analysis (Chrompac 
cyclodextrin-β-236M-19 50m, gas He, T = 150 0C, P = 15 
psi, ketone 13.7 min, R isomer 20.7 min., S isomer 22.4 
min.); [α]D
33 = + 44.5 (c 0.7 in CHCl3) 70% ee (R) (lit.20 
[α]D
20 +41 (c 1.0 in CHCl3) 67% ee (R)); δH (400 MHz; 
CDCl3)/ppm: 7.56 (1H, dd, J 7.8 and 1.8, Ar-H), 7.32-7.25 
(2H, m, Ar-H), 7.18 (1H, td, J 7.7 and 1.8, Ar-H), 5.26 (1H, 
dq, J 6.3 and 2.8, PhCHCH3), 2.33 (1H, br d, J 3.0, OH), 
1.46 (3H, d, J 6.5, CH3); δC (100.6 MHz; CDCl3)/ppm: 
143.1, 131.6, 129.4, 128.4, 127.2, 126.4 (Ar-C), 66.9 
(CH),23.5 (CH3). 
1-(2’-Bromophenyl)ethanol: Enantiomeric excess and 
conversion by GC analysis through its acetate derivative 
(Chrompac cyclodextrin-β-236M-19 50m, gas He,  T = 160 
0C, P = 15 psi, Ketone 15.4 min., R isomer 21.8   min., S 
isomer 23.6 min.); [α]D33 + 27 (c 0.6 in CHCl3) 54 % ee (R) 
(lit.21 [α]D20 = −39.5  (c= 0.96, CHCl3) 81 % ee (S); δH (300 
MHz; CDCl3)/ppm: 7.59 – 7.06  (4H, m, Ar-H), 5.20 (1H, 
q, J 6.3, CH α-OH), 1.44 (3H, d, J 6.3, CH3). δC (75 MHz; 
CDCl3)/ppm: 144.0, 132.0, 128.1, 127.2, 126.0, 121.0 (Ar-
C), 68.5 (CH), 22.9 (CH3). 
1-(2,5-dimethoxyphenyl)ethanol: Enantiomeric excess 
and conversion by GC analysis (Chrompac cyclodextrin-β-
236M-19 50m, gas He, T = 155 0C, P = 15 psi, ketone 40.7 
min., R isomer 49.6 min., S isomer 51.6 min.); [α]D33 + 
18.6 (c 0.5 in CHCl3) 71% ee (R) (lit.22 [α]D25 = +23.8 (c 
2.6 in CHCl3) 91% ee (R)); δH (300 MHz; CDCl3/ppm: 6.96 
– 6.71 (3H, m, Ar-H), 5.05 (1H, m, CH α-OH), 3.81 (3H, s, 
OCH3), 3.76 (3H, s, OCH3), 1.48 (3H, d, J 6.5, CH3). δC (75 
MHz; CDCl3/ppm: 153.7, 150.6, 134.6, 112.4, 112.2, 111.3 
(Ar-C), 66.4 (CH), 55.8 (OCH3),  55.7 (OCH3), 22.9 (CH3). 
1-(2-Trifluoromethylphenyl)ethanol: Enantiomeric 
excess and conversion determined by GC analysis 
(Chrompac cyclodextrin-β-236M-19 50m, gas He, T = 120 
0C, P = 15 psi, ketone 18.1 min, R isomer 31.8 min., S 
isomer 34.1 min.). [α]D33 = + 33 (c 0.16 in CH3OH) 75 % 
ee (R) (lit.19 [α]D22 = −45.5  (c= 0.66, CH3OH) 97 % ee (S); 
δH (400 MHz; CDCl3)/ppm: 7.84 (1H, d, J 7.8, ArH), 7.64-
7.58 (2H, m, ArH), 7.38 (1H, t, J 7.7, ArH), 5.34 (1H, q, J 
6.3, CH(OH)CH3), 1.98 (1H, br s, OH), 1.50 (3H, d, J 6.3, 
CH3); δC (100.6MHz; CDCl3)/ppm: 145.0 (F3C), 132.4, 
127.4, 127.1, 125.7, 125.4, 125.3 (Ar-C), 65.7 (CH), 25.5 
(CH3). 
1-(1’-Naphthyl)ethanol: Enantiomeric excess and 
conversion determined by GC analysis (Chrompac 
cyclodextrin-β-236M-19 50m, gas He, T = 170 0C, P = 10 
psi, ketone 49.1 min, S isomer 70.6 min., R isomer 72.8 
min.); [α]D33 + 65 (c 0.8 in Et2O) 72% ee (R) (lit.23 [α]D28 
+77.2 (c 0.67 in Et2O) 99% ee (R)); δH (300 MHz; 
CDCl3)/ppm: 8.09 (1H, d, J 8.0, Ar-H), 7.87-7.83 (1H, m, 
Ar-H), 7.76 (1H, d, J 8.3, Ar-H), 7.65 (1H, d, J 7.0, Ar-H), 
7.53-7.43 (3H, m, Ar-H), 5.64 (1H, q, J 6.4, CH(OH)CH3), 
2.05 (1H, br s, OH), 1.65 (3H, d, J 6.5, CH3); δC (75 MHz; 
CDCl3)/ppm: 141.5, 133.8, 130.3, 128.9, 127.9, 126.0, 
125.6, 125.5, 123.2, 122.1 (Ar-C), 67.1 (CH), 24.4 (CH3). 
1-phenyl-2,2-dimethyl-1-propanol: Enantiomeric excess 
and conversion determined by GC analysis through its 
acetate derivative (Chrompac cyclodextrin-β- 236M-19 
50m, gas He, T = 125 0C, P = 10 psi, ketone 39.6 min, R 
isomer (acetate) 59.7 min., S isomer (acetate) 58.2 min.); 
[α]D
33 + 28 (c 0.55 in acetone) 72% ee (R) (lit.24 [α]D20 − 
30.3 (c 0.3 in acetone) 100% ee (S)); δH (300 MHz; 
CDCl3)/ppm: 7.28 – 7.19 (5H, m, Ar-H), 4.33 (1H, s, 
PhCHOH), 0.88 (9H, s, 3CH3).    δC (75 MHz; 
CDCl3)/ppm: 141.5, 127.0, 126.9, 126.6 (Ar-C), 81.7 (CH), 
35.0 (C), 25.3 (3CH3). 
1-Tetralol: Enantiomeric excess and conversion 
determined by GC analysis through its acetate derivative 
(Chrompac cyclodextrin-β- 236M-19 50m, gas He, T = 140 
0C, P = 15 psi, ketone 47.2 min, R isomer (acetate) 62.9 
min., S isomer (acetate) 64.2  min.); [α]D35 − 15 (c 0.37 in 
CHCl3) 53 % ee (R) (lit.25 [α]D27 −32.3 (c 1.00 in CHCl3) 
98% ee (R)); δH (400 MHz; CDCl3)/ppm: 7.43-7.38 (1H, 
m, Ar-H), 7.21- 7.15 (2H, m, Ar-H), 7.10-7.06 (1H, m, Ar-
H), 4.74 (1H, br s, CHOH), 2.85-2.66 (2H, m, CH2 ortho to 
CHOH), 2.00-1.70 (5H, m, 2 × CH2 + OH); δC (100.6 
MHz; CDCl3)/ppm: 138.9, 137.1, 129.0, 128.7, 127.6, 
126.2 (Ar-C), 68.1 (CH), 32.3 (CH2), 29.3 (CH2), 18.9 
(CH2). 
1-(4’-Methoxyphenyl)ethanol: Enantiomeric excess and 
conversion determined by GC analysis (Chrompac 
cyclodextrin-β-236M-19 50m, gas He, T = 130 0C, P = 15 
psi, ketone 65.96 min, R isomer 71.8 min., S isomer 74.3 
min.); [α]D
32 + 33.8 (c 0.54 in CHCl3) 67 % ee (R) (lit.25 
[α]D27 +32.3 (c 1.00 in CHCl3) 90% ee (R)); δH (400 MHz; 
CDCl3)/ppm: 7.30-7.26 (2H, m, Ar-H), 6.89-6.85 (2H, m, 
Ar-H), 4.83 (1H, q, J 6.3, PhCHCH3), 3.79 (3H, s, OCH3), 
2.02 (1H, br s, OH), 1.46 (3H, d, J 6.3, CH3); δC (100.6 
MHz; CDCl3)/ppm: 159.0 (next to OCH3), 138.1, 126.7, 
113.9 (Ar-C), 70.0 (CH), 55.3 (OCH3), 25.0 (CH3). 
1-(4-methylphenyl)ethanol: Enantiomeric excess and 
conversion determined by GC analysis (Chrompac 
cyclodextrin-β-236M-19 50m, gas He, T = 125 0C, P = 15 
psi, ketone 28.3 min, R isomer 35.2 min., S isomer 38.1 
min.); [α]D
33 + 38 (c 0.72 in CHCl3) 61% ee (R) (lit.18 
[α]D26 –53.0 (c 0.55, CHCl3) for 92% ee (S)). δH (300 MHz; 
CDCl3)/ppm: 7.22 – 7.15 (2H, m, Ar-H), 7.12 – 7.06 (2H, 
m, Ar-H), 4.73 (1H, q, J 6.4, PHCHOH), 2.30 (3H, s, CH3), 
1.38 (3H, d, J 6.4). δC (75 MHz; CDCl3)/ppm: 143.0, 136.9, 
129.1, 125.4 (Ar-C), 70.0 (CH), 25.1 (CH3), 21.1 (CH3). 
1-Phenylpropan-1-ol: Enantiomeric excess and conversion 
determined by GC analysis (Chrompac cyclodextrin-β-
236M-19 50m, gas He, T = 115 0C, P = 15 psi, ketone 29.3 
min, R isomer 45.8 min., S isomer 47.9 min.); [α]D33 + 33 
(c 1 in CHCl3) 62% ee (R) (lit.26 [α]D20 +47.0 (c 1.4 in 
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CHCl3) 95% ee (R)); δH (400 MHz; CDCl3)/ppm: 7.36-7.24 
(5H, m, Ar-H), 4.57 (1H, t, J 6.5,PhCH(OH)CH2), 2.00 
(1H, br s, OH), 1.86-1.68 (2H, m, CH2), 0.90 (3H, t, J 7.4, 
CH3); δC (100.6 MHz; CDCl3)/ppm: 144.6, 128.4, 127.5, 
126.0 (Ar-C), 76.0 (CH), 31.9 (CH2), 10.2 (CH3). 
1-(3-methylphenyl)ethanol: Enantiomeric excess and 
conversion determined by GC analysis (Chrompac 
cyclodextrin-β-236M-19 50m, gas He, T = 125 0C, P = 15 
psi, ketone 26.1 min, R isomer 37.7 min., S isomer 38.8 
min.); [α]D
33 + 34.6 (c 0.8 in CHCl3) 65% ee (R) (lit.18 
[α]D26 –42.6(c 0.62, CHCl3) for 84% ee (S)). δH (300 MHz; 
CDCl3)/ppm: 7.26 – 7.4 (4H, m, Ar-H), 4.80 (1H, q, J 6.4, 
PHCHOH), 2.34 (3H, s, CH3), 1.44 (3H, d, J 6.4). δC (75 
MHz; CDCl3)/ppm: 145.8, 138.1, 128.4, 128.2, 126.1, 
122.4 (Ar-C), 70.3 (CH), 25.1 (CH3), 21.4 (CH3). 
1-(3’-Methoxyphenyl)ethanol: Enantiomeric excess and 
conversion determined by GC analysis (Chrompac 
cyclodextrin-β-236M-19 50m, gas He,  T = 140 0C, P = 15 
psi, ketone 33.4 min, R isomer 48.8 min., S isomer 51.0 
min.); [α]D33 + 21.6 (c 0.74 in MeOH) 61 % ee (R) (lit.19 
[α]D22 −34.9 (c 0.849 in MeOH) >99% ee (S)); δH (400 
MHz; CDCl3)/ppm: 7.26 (1H, dd, J1 = J2 8.0, Ar-H), 6.96-
6.92 (2H, m, Ar-H), 6.83-6.79 (1H, m, Ar-H), 4.86 (1H, q, 
J 6.4, CH(OH)CH3), 3.81 (3H, s, ArOCH3), 1.94 (1H, br s, 
OH), 1.48 (3H, d, J 6.5, CH3); δC (100.6 MHz; 
CDCl3)/ppm: 159.8 (ArC-OMe), 147.6, 129.6, 117.7, 
112.9, 110.9 (Ar-C), 70.4 (CH), 55.2 (OCH3), 25.2 (CH3). 
2-Methyl-1-phenylpropan-1-ol: Enantiomeric excess and 
conversion by GC analysis (Chrompac cyclodextrin-β-
236M-19 50m, gas He,  T = 115 0C, P = 10 psi, ketone 45.8 
min., R isomer 90.7 min., S isomer 92.1 min.); [α]D33 =  + 
33 (c 0.47 in ether) 71% ee (R) (lit.19 [α]D25 −49.1 (c 0.85 in 
ether) 99% ee (S)); δH (400 MHz; CDCl3/ppm: 7.37 – 7.22 
(5H, m, Ar-H), 4.33 (1H, d, J 6.9, CH α-OH), 2.00 – 1.88 
(1H, m, CH), 0.99 (3H, d, J 6.6, CH3), 0.78 (3H, d, J 6.8, 
CH3). δC (100.6 MHz; CDCl3/ppm: 143.0, 127.5, 126.8, 
125.9 (Ar-C), 79.4 (CH), 34.6 (CH), 18.3 (CH3), 17.6 
(CH3). 
1-(2,5-dimethylphenyl)ethanol: Enantiomeric excess and 
conversion by GC analysis (Chrompac cyclodextrin-β-
236M-19 50m, gas He, T = 140 0C, P = 15 psi, ketone 21.8 
min., R isomer 36.5 min., S isomer 39.9 min.); [α]D33 = + 
64 (c 0.5 in CHCl3) 85 % ee (R) (lit.15 [α]D27 −61.7 (c 0.6 in 
CHCl3) 83 % ee (S)). δH (300 MHz; CDCl3/ppm: 7.32 – 
6.92 (3H, m, Ar-H), 5.03 (1H, q, J 6.4, CH α-OH), 2.31 
(3H, s, CH3), 2.26 (3H, s, CH3), 1.41 (3H, d, J 6.4, CH3). δC 
(75 MHz; CDCl3/ppm: 143.7, 135.8, 131.0, 130.3, 127.8, 
125.1 (Ar-C), 66.7 (CH), 23.9 (CH3), 21.1 (CH3), 18.4 
(CH3). 
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Captions for schemes and figures: 
Scheme 1: Asymmetric ketone reduction using a 
combination of IrCl3 and a diamine ligand.15 
Scheme 2: Preparation of ligands 9a- 9q. 
Table 1: Asymmetric hydrogenation of 2-
methylacetophenone using IrCl3 with diamine ligands 9a-
9q.a 
Table 2: Asymmetric hydrogenation of ketones using IrCl3 
with diamine ligand 9o, 9d and 9f.a 
 
 
 
 
 
 
 
 
 
